TRANSMEDICS GROUP INC
TransMedics Group Inc (TMDX) develops organ preservation and transport systems designed to improve transplant outcomes and expand donor organ utilisation. Its flagship Organ Care System (OCS) platforms keep hearts, lungs and livers functioning outside the body by perfusing them with warm, oxygenated blood, enabling longer preservation, active assessment and potential use of marginal donors. The company generates revenue from capital equipment sales and recurring disposables used for each transplant, supported by training and clinical data to drive adoption. Growth depends on clinical acceptance, reimbursement, regulatory approvals and transplant volumes; the business can offer attractive recurring revenue if hospitals scale use. Key risks include regulatory or clinical setbacks, reimbursement uncertainty, hospital purchasing cycles, competition and historical operating losses. Market cap is approximately US$4.1bn (provided). This is general educational information, not personal financial advice; values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying TransMedics Group’s stock, expecting its price to rise in the future.
Financial Health
TransMedics is showing strong revenue and cash flow, indicating a healthy financial position.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TMDX
Wearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables Demand
Each transplant uses single‑use disposables, offering recurring revenue potential as procedures scale, though volumes rely on adoption and reimbursement.
Clinical Outcomes Focus
OCS lets clinicians assess organs outside the body, which may increase usable donors; clinical evidence and trial results will influence uptake.
Addressing Organ Shortage
The global transplant market is substantial and the technology targets unmet need, but growth depends on hospital budgets, regulation and payer support.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
